• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法布里病中心脏形态和功能表现的变化:对疾病病程的潜在影响。

The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease.

作者信息

Weidemann Frank, Breunig Frank, Beer Meinrad, Sandstede Joern, Störk Stefan, Voelker Wolfram, Ertl Georg, Knoll Anita, Wanner Christoph, Strotmann Joerg M

机构信息

Department of Internal Medicine I, Divisions of Cardiology and Nephrology, Medical University Clinic, University of Würzburg, 97080 Wuerzburg, Germany.

出版信息

Eur Heart J. 2005 Jun;26(12):1221-7. doi: 10.1093/eurheartj/ehi143. Epub 2005 Feb 23.

DOI:10.1093/eurheartj/ehi143
PMID:15728649
Abstract

AIMS

The aim of this clinical cross-sectional study was to investigate the cardiac interrelation of morphological and functional abnormalities in patients with Fabry disease.

METHODS AND RESULTS

Fifty-one patients (5-78 years) were compared with 25 controls (8-77 years). In all subjects, end-diastolic thickness of the left ventricle was measured by echocardiography and ultrasonic peak systolic strain rate (SR) was extracted to assess regional myocardial function. Magnetic resonance imaging was performed to assess late-enhancement for the detection of myocardial fibrosis in Fabry patients (n=39). In patients, women <20 years of age had no hypertrophy, no late-enhancement, and normal radial and longitudinal function (SR longitudinal=-1.7+/-0.5 s(-1); P=n.s. compared with controls). Ten women, >20 years of age, had no hypertrophy, no late-enhancement, normal radial and longitudinal function in the septal wall, but reduced longitudinal function in the lateral wall (SR=-1.4+/-0.5 s(-1)). All male patients without hypertrophy and no late-enhancement had normal radial function but reduced longitudinal function in both the septal and lateral walls (SR=-1.3+/-0.3 s(-1)). Patients with hypertrophy but without late-enhancement (n=13) had reduced radial and longitudinal function. Twelve patients displaying hypertrophy and late-enhancement had severely reduced radial and longitudinal function (SR=-1.1+/-0.5 s(-1)). Two of them with the worst impairment of regional function (SR=-0.8+/-0.6 s(-1)) died in the follow-up period.

CONCLUSION

These results illustrate the variation of morphological changes and its functional consequences in Fabry cardiomyopathy.

摘要

目的

本临床横断面研究旨在调查法布里病患者形态学和功能异常之间的心脏内在关系。

方法与结果

将51例患者(年龄5 - 78岁)与25例对照者(年龄8 - 77岁)进行比较。对所有受试者采用超声心动图测量左心室舒张末期厚度,并提取超声峰值收缩应变率(SR)以评估局部心肌功能。对法布里病患者(n = 39)进行磁共振成像以评估延迟强化,用于检测心肌纤维化。在患者中,年龄小于20岁的女性无心肌肥厚、无延迟强化,径向和纵向功能正常(纵向SR = -1.7±0.5 s⁻¹;与对照组相比,P无统计学意义)。10例年龄大于20岁的女性无心肌肥厚、无延迟强化,室间隔壁的径向和纵向功能正常,但侧壁纵向功能降低(SR = -1.4±0.5 s⁻¹)。所有无心肌肥厚且无延迟强化的男性患者径向功能正常,但室间隔壁和侧壁的纵向功能均降低(SR = -1.3±0.3 s⁻¹)。有心肌肥厚但无延迟强化的患者(n = 13)径向和纵向功能降低。12例有心肌肥厚且有延迟强化的患者径向和纵向功能严重降低(SR = -1.1±0.5 s⁻¹)。其中2例局部功能损害最严重(SR = -0.8±0.6 s⁻¹)的患者在随访期间死亡。

结论

这些结果说明了法布里心肌病形态学变化及其功能后果的差异。

相似文献

1
The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease.法布里病中心脏形态和功能表现的变化:对疾病病程的潜在影响。
Eur Heart J. 2005 Jun;26(12):1221-7. doi: 10.1093/eurheartj/ehi143. Epub 2005 Feb 23.
2
[Quantitative evaluation of regional myocardial function using strain and strain rate imaging: normal values in pediatric age].[应用应变及应变率成像技术对局部心肌功能进行定量评估:儿童期正常值]
Ital Heart J Suppl. 2005 Jul;6(7):420-6.
3
Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment.法布里心肌病在男性和女性患者中的差异:对诊断评估的影响。
JACC Cardiovasc Imaging. 2011 Jun;4(6):592-601. doi: 10.1016/j.jcmg.2011.01.020.
4
Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study.心脏法布里病患者的终末期心脏表现:一项心电图、超声心动图及尸检研究
J Cardiol. 2008 Feb;51(1):50-9. doi: 10.1016/j.jjcc.2007.12.001. Epub 2008 Feb 6.
5
Impact of right ventricular dilation on left ventricular myocardial deformation in patients after surgical repair of tetralogy of fallot.法洛四联症手术修复术后患者右心室扩张对左心室心肌变形的影响。
Am J Cardiol. 2009 Nov 1;104(9):1264-70. doi: 10.1016/j.amjcard.2009.06.043.
6
Two-dimensional speckle tracking as a non-invasive tool for identification of myocardial fibrosis in Fabry disease.二维斑点追踪作为一种无创工具用于鉴定法布里病心肌纤维化。
Eur Heart J. 2013 Jun;34(21):1587-96. doi: 10.1093/eurheartj/eht098. Epub 2013 Mar 21.
7
Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment.酶替代疗法对法布里心肌病的长期影响:早期治疗带来更好预后的证据。
Circulation. 2009 Feb 3;119(4):524-9. doi: 10.1161/CIRCULATIONAHA.108.794529. Epub 2009 Jan 19.
8
Regional diastolic dysfunction in individuals with left ventricular hypertrophy measured by tagged magnetic resonance imaging--the Multi-Ethnic Study of Atherosclerosis (MESA).通过标记磁共振成像测量左心室肥厚个体的局部舒张功能障碍——动脉粥样硬化多民族研究(MESA)
Am Heart J. 2006 Jan;151(1):109-14. doi: 10.1016/j.ahj.2005.02.018.
9
Tei index in fabry disease.法布里病的 Tei 指数。
J Am Soc Echocardiogr. 2011 Sep;24(9):1026-32. doi: 10.1016/j.echo.2011.05.021. Epub 2011 Jun 29.
10
Altered myocardial motion pattern in Fabry patients assessed with CMR-tagging.采用心脏磁共振标记成像评估法布里病患者心肌运动模式的改变。
J Cardiovasc Magn Reson. 2007;9(6):891-8. doi: 10.1080/10976640701693691.

引用本文的文献

1
The Complex Puzzle of Hypertrophic Phenotype: A Practical Approach for the Clinician.肥厚型表型的复杂谜题:临床医生的实用方法
Arq Bras Cardiol. 2025 Mar;122(1):e20240529. doi: 10.36660/abc.20240529.
2
Fabry Disease Cardiomyopathy: A Review of the Role of Cardiac Imaging from Diagnosis to Treatment.法布里病心肌病:从诊断到治疗的心脏成像作用综述
Rev Cardiovasc Med. 2022 May 27;23(6):192. doi: 10.31083/j.rcm2306192. eCollection 2022 Jun.
3
Echocardiography in Anderson-Fabry Disease.安德森-法布里病的超声心动图检查
Rev Cardiovasc Med. 2022 May 31;23(6):201. doi: 10.31083/j.rcm2306201. eCollection 2022 Jun.
4
Anderson-Fabry Disease: Red Flags for Early Diagnosis of Cardiac Involvement.安德森-法布里病:心脏受累早期诊断的警示信号。
Diagnostics (Basel). 2024 Jan 18;14(2):208. doi: 10.3390/diagnostics14020208.
5
Clinical staging of Anderson-Fabry cardiomyopathy: An operative proposal.安德森-法布里心肌病的临床分期:一项手术方案建议。
Heart Fail Rev. 2024 Mar;29(2):431-444. doi: 10.1007/s10741-023-10370-x. Epub 2023 Nov 25.
6
Hypertrophic Cardiomyopathy versus Storage Diseases with Myocardial Involvement.肥厚型心肌病与心肌受累的贮积病的比较。
Int J Mol Sci. 2023 Aug 26;24(17):13239. doi: 10.3390/ijms241713239.
7
Circulated TGF-β1 and VEGF-A as Biomarkers for Fabry Disease-Associated Cardiomyopathy.循环 TGF-β1 和 VEGF-A 作为法布里病相关性心肌病的生物标志物。
Cells. 2023 Aug 19;12(16):2102. doi: 10.3390/cells12162102.
8
The role of imaging in the selection of patients for HFpEF therapy.影像学在射血分数保留型心力衰竭(HFpEF)患者治疗选择中的作用。
Eur Heart J Cardiovasc Imaging. 2023 Sep 26;24(10):1343-1351. doi: 10.1093/ehjci/jead137.
9
Comparison of classical Fabry and its p.D313Y and p.A143T variants by cardiac T1 mapping, LGE and feature tracking myocardial strain.采用心脏 T1 映射、LGE 和特征追踪心肌应变技术对经典 Fabry 病及其 p.D313Y 和 p.A143T 变体进行比较。
Sci Rep. 2023 Apr 10;13(1):5809. doi: 10.1038/s41598-023-32464-0.
10
The Frequency of Fabry Disease in Patients with Cardiac Hypertrophy of Various Phenotypes Including Prominent Papillary Muscle: The TUCARFAB Study in Turkey.土耳其 TUCARFAB 研究:包括显著乳头肌在内的各种表型心脏肥厚患者中 Fabry 病的频率。
Anatol J Cardiol. 2023 Apr;27(4):223-228. doi: 10.14744/AnatolJCardiol.2022.2503.